Product Information
MYCOPHENOLIC ACID DR 180 MG TB is a generic product labeled by Archis Pharma LLC, priced at $0.0996 per EA under NDC 72819015508. Its NADAC has been published 178 times since May 10, 2023.
FDA first approved this application on Jan 8, 2014.
Strength
180 mg/1
Manufacturer
Archis Pharma LLCNDC
72819015508
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MYCOPHENOLIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA091248FDA Approved
1/8/2014
On Market Since
2/21/2022
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLIC ACID DR 180 MG TB has been published 178 times since May 10, 2023, and over the history we have for it it has declined 57.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0996 per EA |
|---|---|
| All-time high | $0.2325 (May 10, 2023) |
| All-time low | $0.0985 (Aug 19, 2026) |
| 52-week high | $0.1449 |
| 52-week low | $0.0985 |
| Median price | $0.1544 |
| Average price | $0.1526 |
| Largest weekly change | +29.4% (Jun 19, 2024) |
| Weeks tracked | 178 |
| Tracking since | May 10, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the mycophenilic acid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Archis Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
mycophenilic acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MYCOPHENOLIC ACID DR 180 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLIC ACID DR 180 MG TB, manufactured by Archis Pharma LLC, is $0.0996 per EA (NDC 72819015508), effective Sep 30, 2026.
How has the price of MYCOPHENOLIC ACID DR 180 MG TB changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLIC ACID DR 180 MG TB has declined 57.2%. It has been tracked across 178 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLIC ACID DR 180 MG TB?
Since May 10, 2023, the NADAC for MYCOPHENOLIC ACID DR 180 MG TB has ranged from a low of $0.0985 (Aug 19, 2026) to a high of $0.2325 (May 10, 2023), with a median of $0.1544 per EA.
Are there cheaper alternatives to MYCOPHENOLIC ACID DR 180 MG TB?
No other NADAC-published product currently shares the active ingredient and strength of MYCOPHENOLIC ACID DR 180 MG TB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MYCOPHENOLIC ACID DR 180 MG TB?
MYCOPHENOLIC ACID DR 180 MG TB (NDC 72819015508) is labeled by Archis Pharma LLC, and CMS classifies it as a generic product.